Cover Image
Market Research Report

Global Heart Valve Repair and Replacement Devices Market 2019-2023

Published by TechNavio (Infiniti Research Ltd.) Product code 823159
Published Content info 127 Pages
Delivery time: 1-2 business days
Price
Back to Top
Global Heart Valve Repair and Replacement Devices Market 2019-2023
Published: March 29, 2019 Content info: 127 Pages
Description

About this market

The increasing prevalence of cardiovascular diseases will drive the heart valve repair and replacement devices market growth in the forthcoming years. Disorders including the aortic stenosis, pulmonary stenosis, and a congenital heart defect have led to rising demand for heart valve repair and replacement devices. In addition, factors including tobacco abuse, high cholesterol, blood pressure, and obesity are also mainly responsible for creating a rising demand for heart valve repair and replacement devices in the long run. Technavio's analysts have predicted that the heart valve repair and replacement devices market will register a CAGR of nearly 16% by 2023.

Market Overview

Rising demand for heart valve therapies

One of the growth drivers of the global heart valve repair and replacement devices market is the rising demand for heart valve therapies. The growing incidence of heart valve diseases such as stenosis and regurgitation led to the high demand for heart valve therapies such as heart valve repair and replacement.

Shortage of cardiologists

One of the challenges in the growth of the global heart valve repair and replacement devices market is the shortage of cardiologists. Lack of expertise increases the probability of misdiagnosis and improper treatment care, which can cause harm to patients.

For the detailed list of factors that will drive and challenge the growth of the heart valve repair and replacement devices market during 2019-2023, view our report.

Competitive Landscape

The market appears to be moderately fragmented with the presence of several market players. Vendors in the market are focusing on strategies such as mergers and acquisitions, partnerships, and other developments to improve their market share and expand their presence globally. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market's competitive landscape and offering information on the products offered by companies.

Table of Contents
Product Code: IRTNTR31074

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Preface
  • 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY PRODUCT

  • Market segmentation by product
  • Comparison by product
  • Heart valve replacement devices - Market size and forecast 2018-2023
  • Heart valve repair devices - Market size and forecast 2018-2023
  • Market opportunity by product

PART 07: MARKET SEGMENTATION BY SURGERY

  • Market segmentation by surgery
  • Comparison by surgery
  • Minimally invasive surgeries - Market size and forecast 2018-2023
  • Transcatheter surgeries - Market size and forecast 2018-2023
  • Open surgeries - Market size and forecast 2018-2023
  • Market opportunity by surgery

PART 08: CUSTOMER LANDSCAPE

PART 09: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity

PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 12: MARKET TRENDS

  • Technological advances
  • Development of heart valve with tissue engineering approach
  • Industry developments

PART 13: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 14: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Abbott
  • Boston Scientific Corporation
  • CryoLife, Inc
  • Edwards Lifesciences Corporation
  • LivaNova PLC
  • Medtronic

PART 15: APPENDIX

  • Research methodology
  • List of abbreviations

PART 16: EXPLORE TECHNAVIO

List of Exhibits

  • Exhibit 01: Global medical devices market
  • Exhibit 02: Segments of global medical devices market
  • Exhibit 03: Market characteristics
  • Exhibit 04: Market segments
  • Exhibit 05: Market definition - Inclusions and exclusions checklist
  • Exhibit 06: Market size 2018
  • Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
  • Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
  • Exhibit 09: Five forces analysis 2018
  • Exhibit 10: Five forces analysis 2023
  • Exhibit 11: Bargaining power of buyers
  • Exhibit 12: Bargaining power of suppliers
  • Exhibit 13: Threat of new entrants
  • Exhibit 14: Threat of substitutes
  • Exhibit 15: Threat of rivalry
  • Exhibit 16: Market condition - Five forces 2018
  • Exhibit 17: Product - Market share 2018-2023 (%)
  • Exhibit 18: Comparison by product
  • Exhibit 19: Heart valve replacement devices - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 20: Heart valve replacement devices - Year-over-year growth 2019-2023 (%)
  • Exhibit 21: Heart valve repair devices - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 22: Heart valve repair devices - Year-over-year growth 2019-2023 (%)
  • Exhibit 23: Market opportunity by product
  • Exhibit 24: Surgery - Market share 2018-2023 (%)
  • Exhibit 25: Comparison by surgery
  • Exhibit 26: Minimally invasive surgeries - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 27: Minimally invasive surgeries - Year-over-year growth 2019-2023 (%)
  • Exhibit 28: Transcatheter surgeries - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 29: Transcatheter surgeries - Year-over-year growth 2019-2023 (%)
  • Exhibit 30: Open surgeries - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 31: Open surgeries - Year-over-year growth 2019-2023 (%)
  • Exhibit 32: Market opportunity by surgery
  • Exhibit 33: Customer landscape
  • Exhibit 34: Market share by geography 2018-2023 (%)
  • Exhibit 35: Geographic comparison
  • Exhibit 36: North America - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 37: North America - Year-over-year growth 2019-2023 (%)
  • Exhibit 38: Europe - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 39: Europe - Year-over-year growth 2019-2023 (%)
  • Exhibit 40: Asia - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 41: Asia - Year-over-year growth 2019-2023 (%)
  • Exhibit 42: ROW - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 43: ROW - Year-over-year growth 2019-2023 (%)
  • Exhibit 44: Key leading countries
  • Exhibit 45: Market opportunity
  • Exhibit 46: Impact of drivers and challenges
  • Exhibit 47: Vendor landscape
  • Exhibit 48: Landscape disruption
  • Exhibit 49: Vendors covered
  • Exhibit 50: Vendor classification
  • Exhibit 51: Market positioning of vendors
  • Exhibit 52: Abbott - Vendor overview
  • Exhibit 53: Abbott - Business segments
  • Exhibit 54: Abbott - Organizational developments
  • Exhibit 55: Abbott - Geographic focus
  • Exhibit 56: Abbott - Segment focus
  • Exhibit 57: Abbott - Key offerings
  • Exhibit 58: Boston Scientific Corporation - Vendor overview
  • Exhibit 59: Boston Scientific Corporation - Business segments
  • Exhibit 60: Boston Scientific Corporation - Organizational developments
  • Exhibit 61: Boston Scientific Corporation - Geographic focus
  • Exhibit 62: Boston Scientific Corporation - Segment focus
  • Exhibit 63: Boston Scientific Corporation - Key offerings
  • Exhibit 64: CryoLife, Inc - Vendor overview
  • Exhibit 65: CryoLife, Inc - Business segments
  • Exhibit 66: CryoLife, Inc - Organizational developments
  • Exhibit 67: CryoLife, Inc - Geographic focus
  • Exhibit 68: CryoLife, Inc - Segment focus
  • Exhibit 69: CryoLife, Inc - Key offerings
  • Exhibit 70: Edwards Lifesciences Corporation - Vendor overview
  • Exhibit 71: Edwards Lifesciences Corporation - Product segments
  • Exhibit 72: Edwards Lifesciences Corporation - Organizational developments
  • Exhibit 73: Edwards Lifesciences Corporation - Geographic focus
  • Exhibit 74: Edwards Lifesciences Corporation - Segment focus
  • Exhibit 75: Edwards Lifesciences Corporation - Key offerings
  • Exhibit 76: LivaNova PLC - Vendor overview
  • Exhibit 77: LivaNova PLC - Business segments
  • Exhibit 78: LivaNova PLC - Organizational developments
  • Exhibit 79: LivaNova PLC - Geographic focus
  • Exhibit 80: LivaNova PLC - Segment focus
  • Exhibit 81: LivaNova PLC - Key offerings
  • Exhibit 82: Medtronic - Vendor overview
  • Exhibit 83: Medtronic - Business segments
  • Exhibit 84: Medtronic - Organizational developments
  • Exhibit 85: Medtronic - Geographic focus
  • Exhibit 86: Medtronic - Segment focus
  • Exhibit 87: Medtronic - Key offerings
  • Exhibit 88: Validation techniques employed for market sizing
Back to Top